"D\u00EDt\u011B, Petr" . . . "GB - Spojen\u00E9 kr\u00E1lovstv\u00ED Velk\u00E9 Brit\u00E1nie a Severn\u00EDho Irska" . "A Prokinetic Agent with a Dual Effect - Itopride - In the Treatment of Dysmotility"@en . "Do\u010Dkal, Milan" . . . "EMJ Gastroenterology" . . "A wide range of dyspeptic symptoms in clinical practice reflect the high prevalence of functional disorders of the gastrointestinal (GI) tract. Prokinetic agents are the current mainstay in the therapy of functional dyspepsia. One of these drugs is itopride. We evaluated therapeutic efficacy of itopride according to the literature review. The therapeutic potential of itopride is connected with a dual effect: influencing of enzyme acetylcholinesterase activity and blocking dopamine D2 receptors."@en . . . "2054-6203" . "1068" . . "4"^^ . . "3"^^ . "Gastro-oesophageal reflux; gastric motility; gastroduodenal coordination; functional dyspepsia; prokinetic agents; itopride; dopamine D2 receptor; acetylcholinesterase"@en . . "I" . "[D22F90A573CC]" . "17110" . . "Rydlo, Martin" . "A wide range of dyspeptic symptoms in clinical practice reflect the high prevalence of functional disorders of the gastrointestinal (GI) tract. Prokinetic agents are the current mainstay in the therapy of functional dyspepsia. One of these drugs is itopride. We evaluated therapeutic efficacy of itopride according to the literature review. The therapeutic potential of itopride is connected with a dual effect: influencing of enzyme acetylcholinesterase activity and blocking dopamine D2 receptors." . "Mart\u00EDnek, Arno\u0161t" . . . . "A Prokinetic Agent with a Dual Effect - Itopride - In the Treatment of Dysmotility" . "A Prokinetic Agent with a Dual Effect - Itopride - In the Treatment of Dysmotility"@en . . "6"^^ . "RIV/61988987:17110/14:A1501CGZ" . "RIV/61988987:17110/14:A1501CGZ!RIV15-MSM-17110___" . . . . . "A Prokinetic Agent with a Dual Effect - Itopride - In the Treatment of Dysmotility" . "3" . . .